SEC Form 4 · accession 0001214659-15-006754
NEULION, INC. · NLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J Christopher Wagner
Officer — EVP, Marketplace Strategy
Period of report
Sep 23, 2015
Accepted (ET)
Sep 24, 2015 · 11:59 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001387713
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 23, 2015 | S | 92,801 | $0.528 | D | 1,279,253 | D | |
| Restricted Common StockF3 | holding | — | — | — | 200,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Mr. Wagner sold these shares to Charles B. Wang, the Chairman of the Board of Directors of NeuLion.
- F2The purchase price of each share was Cdn$0.70, which was the closing price of NeuLion's common stock on the Toronto Stock Exchange on September 22, 2015. The price was converted to US dollars using a rate of 0.7543, which was the closing foreign exchange rate of the Bank of Canada on September 22, 2015.
- F3The reporting person was granted these shares of restricted common stock subject to the terms of the Amended and Restated NeuLion, Inc. 2012 Omnibus Securities and Incentive Plan. The shares of restricted common stock vest at a rate of one-quarter of their allotted amount per year over four years.